Abstract:OBJECTIVE:To screen out the specific antibody clones against amyloid beta peptide 40, and clone the antibody gene and express it in a bacterial system, so as to provide a solid basis for novel diagnostic and therapeutic methods for Alzheimer's Disease.METHODS:beta amyloid peptide 40 was bound on the solid surface of Nunc plates as antigen to screen the binding clones from a phage-display human single-chain Fv antibody library. After five rounds of bio-panning, the host E. coli TG1 was infected with eluted filamentous phage from the last turn of selection. 55 well-separated colonies were picked randomly from the plates and the specific positive clones were identified by ELISA test. The single-chain Fv antibody gene was sequenced and their amino acids sequence was deduced. The scFv antibody gene was sub-cloned into a protokayotic expression vector pGEX-6P-1 and transformed into bacteria strain BL21 to express the glutathione-S-transferase (GST) fusion single-chain antibody.RESULTS:ELISA test showed that 33 of the 55 clones could bind amyloid beta peptide 40 and 10 of the 33 clones could be inhibited by amyloid beta peptide 40 itself to below 50% of its original binding activities. Five of the 10 clones could also be inhibited by amyloid beta peptide 1-16 to the same level, which meant that the binding epitope of the antibody from the 5 clones was between first to sixteenth amino acids at amino-end of amyloid beta peptide 40. DNA sequencing data demonstrated that the gene of the single-chain antibody specifically against amyloid beta peptide 40 was consisted of 768 bp and the deduced amino acids sequence confirmed its typical antibody structure. The complement determinant regions and framework regions were discriminated empirically. After cloning the antibody gene into a protokayotic system, the GST fusion antibody was expressed as the expected size.CONCLUSIONS:After five rounds of bio-panning and subsequently serial ELISA testing, the specific antibody clones against amyloid beta peptide 40 were screened out successfully. The antibody gene DNA sequence and amino acids sequence were analyzed and confirmed. The fusion antibody was expressed as expected in the bacterial system.

A Novel Recombinant Vaccine Against Alzheimer's Disease: Cloning, Expression, Purification and Antigenicity Evaluation

[Cloning and Expression of Human Single-Chain Fv Antibody Against Amyloid Beta Peptide Involved in Alzheimer's Disease].

Prophylactic immunotherapy of Alzheimer's disease using recombinant amyloid-β B-cell epitope chimeric protein as subunit vaccine

Oral Administration of a Fusion Protein Between the Cholera Toxin B Subunit and the 42-Amino Acid Isoform of Amyloid-Β Peptide Produced in Silkworm Pupae Protects Against Alzheimer's Disease in Mice.

High Level Expression Purification and Character Research of Human Fusion Antibody for Anti-Aβ in the Yeast Pichia Pastoris

Effects of a 15-Amino-acid Isoform of Amyloid- Β Expressed by Silkworm Pupae on B6C3-Tg Alzheimer’s Disease Transgenic Mice

Prediction of the 3D conformation of a small peptide vaccine targeting Aβ42 oligomers

[Serial Recombinant Expression and Anti-Tumor Activity in Vitro of Antibiotic Peptide Alloferon-1].

An Enzyme-Linked Immunosorbent Assay To Compare The Affinity Of Chemical Compounds For Beta-Amyloid Peptide As A Monomer

Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer’s Disease Model Mice

A pentavalent peptide vaccine elicits Aβ and tau antibodies with prophylactic activity in an Alzheimer's disease mouse model

Recombinant Dna Vaccine Against Neurite Outgrowth Inhibitors Attenuates Behavioral Deficits and Decreases Abeta in an Alzheimer'S Disease Mouse Model

Lignin isolated from steam-exploded eucalyptus wood chips by phase separation and its affinity to Trichoderma reesei cellulase.

[Serial Recombinant Expression and Activity Against Tumor Cells in Vitro of Antibacterial Peptide Alloferon-1].

The Cloning and Expression of an Anti-Alzheimer's Disease Neuroprotective Peptide Gene Humanin

Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers

[Prokaryotic Expression of Staphylococcus Aureus Clumping Factor B and Evaluation of the Antiserum-Mediated Opsonic Activity].

New progress in active immunotherapy targeting to amyloid beta

Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer’s Disease, in Serum and Tissue of Sprague Dawley Rats

An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer’s disease: pyroglutamate amyloid beta

Preparations of Specific Antibodies Against PrP N-terminal or C-terminal Peptides and Preliminary Study on Establishment of ELISA Diagnostic Method